Minimax Medical Group is a pioneering MedTech enterprise strategically located in China &
Europe, and strongly committed to research, manufacture and sales of minimally invasive devices
and surgical robot.
Our self-owned minimally invasive products have established strong supply and market presence in key global marketplaces, ranging from oncology, phlebology, proctology and aesthetic dermatology. Particularly in China, we have achieved sales of our self-owned brands and devices under
distribution in hundreds of 3A-graded Chinese hospitals, and we are proactively capturing opportunities in 2A-grades across the country. We are now vigorously expanding our international brand identity.
To become a dynamic and responsive platform matching prime MedTech technology to growing needs of surgeons and patients internationally; To become a MedTech group with customer orientation, innovation strategies and visionary leadership in the industry; To share our achievement with talents and grow together with them.
MedTech improves the quality of life.
Proactive. Innovative. Professional Focus. Strive For Excellence. Vitality Growth. Prompt Execution.
Minimax medical has a high level R&D team, with more than 20 members in Nan
jing R&D Center and 8 members in American R&D Center, Dr. Jay is the chief
expert of the American R&D Center and he has rich theoretical and practical experience. We have established long term strategic partnership with world-re-
nowned medical experts such as Professor Habib of Imperial College London,
and cooperate with top professors in China on research projects. Besides, we get
access to world’s leading medical technology through participations, holdings
and acquisitions in US and Europe.
We have obtained a number of invention patents in China and abroad, through
innovative work from our R&D team. And our R&D team would continue with
technological exchanges and in depth cooperation with well known scientific
research agencies and institutions both in China and abroad.
